DAILY VERSUS ALTERNATE-DAY ROSUVASTATIN FOR DYSLIPIDEMIA: A RANDOMIZED CONTROLLED STUDY

Authors

  • Ajay Kumar Author
  • Bhanu Priya Singh Author
  • Shallini Gupta Author
  • Pavan Malhotra Author
  • Abid Manzoor Author

DOI:

https://doi.org/10.56802/e8qzhp89

Keywords:

Rosuvastatin,

Abstract

Background: Alternate-day statin therapy has been proposed as a cost-effective strategy to
maintain lipid control while potentially reducing adverse effects; however, comparative data
with daily dosing remain limited.

Downloads

Published

09-03-2026

Issue

Vol. 17 No. 3 (2026): Volume 17 Issue 3 2026

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

DAILY VERSUS ALTERNATE-DAY ROSUVASTATIN FOR DYSLIPIDEMIA: A RANDOMIZED CONTROLLED STUDY. (2026). International Research Journal of Pharmacy, 17(3), 1-11. https://doi.org/10.56802/e8qzhp89